These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26670723)

  • 41. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.
    Cotter G; Cannon CP; McCabe CH; Michowitz Y; Kaluski E; Charlesworth A; Milo O; Bentley J; Blatt A; Krakover R; Zimlichman R; Reisin L; Marmor A; Lewis B; Vered Z; Caspi A; Braunwald E;
    Am Heart J; 2003 Apr; 145(4):622-7. PubMed ID: 12679757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aspirin in the secondary prevention of cardiovascular disease: an update of the APTC meta-analysis.
    Lièvre M; Cucherat M
    Fundam Clin Pharmacol; 2010 Jun; 24(3):385-91. PubMed ID: 19678849
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains.
    Subherwal S; Patel MR; Kober L; Peterson ED; Jones WS; Gislason GH; Berger J; Torp-Pedersen C; Fosbol EL
    Circulation; 2012 Sep; 126(11):1345-54. PubMed ID: 22874581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.
    Feres F; Costa RA; Abizaid A; Leon MB; Marin-Neto JA; Botelho RV; King SB; Negoita M; Liu M; de Paula JE; Mangione JA; Meireles GX; Castello HJ; Nicolela EL; Perin MA; Devito FS; Labrunie A; Salvadori D; Gusmão M; Staico R; Costa JR; de Castro JP; Abizaid AS; Bhatt DL;
    JAMA; 2013 Dec; 310(23):2510-22. PubMed ID: 24177257
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of antiplatelet therapy in patients with peripheral artery disease and lower extremity peripheral artery revascularization.
    Banerjee S; Sarode K; Vinas A; Banerjee A; Mohammad A; Brilakis ES
    Curr Opin Cardiol; 2015 Sep; 30(5):525-35. PubMed ID: 26241710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aortic valve sclerosis in patients with peripheral and/or coronary arterial disease.
    Losi MA; Brevetti G; Schiano V; Barbati G; Parisi V; Contaldi C; Chiacchio E; Cavallaro M; Carpinella G; Fundaliotis A; Parrella LS; Betocchi S; Brevetti L; Chiariello M
    Echocardiography; 2010 Jul; 27(6):608-12. PubMed ID: 20412271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
    Tran H; Anand SS
    JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of polyvascular disease on clinical outcomes in patients undergoing coronary revascularization: an observation from the CREDO-Kyoto Registry Cohort-2.
    Morikami Y; Natsuaki M; Morimoto T; Ono K; Nakagawa Y; Furukawa Y; Sakata R; Aota M; Okada Y; Onoe M; Kawasuji M; Koshiji T; Nakajima H; Nishizawa J; Yamanaka K; Yamamoto H; Kimura T;
    Atherosclerosis; 2013 Jun; 228(2):426-31. PubMed ID: 23623262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and prediction of previously unrecognized peripheral arterial disease in patients with coronary artery disease: the Peripheral Arterial Disease in Interventional Patients Study.
    Moussa ID; Jaff MR; Mehran R; Gray W; Dangas G; Lazic Z; Moses JW
    Catheter Cardiovasc Interv; 2009 May; 73(6):719-24. PubMed ID: 19213068
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of vorapaxar as approved for clinical use in the United States.
    Magnani G; Bonaca MP; Braunwald E; Dalby AJ; Fox KA; Murphy SA; Nicolau JC; Oude Ophuis T; Scirica BM; Spinar J; Theroux P; Morrow DA
    J Am Heart Assoc; 2015 Mar; 4(3):e001505. PubMed ID: 25792124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vorapaxar: A Protease-Activated Receptor Antagonist for the Prevention of Thrombotic Events.
    Lam S; Tran T
    Cardiol Rev; 2015; 23(5):261-7. PubMed ID: 25923910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial.
    Galani J; Mulder H; Rockhold FW; Weissler EH; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Hiatt WR; Katona BG; Norgren L; Mahaffey KW; Quint JK; Patel MR; Jones WS
    Int J Chron Obstruct Pulmon Dis; 2021; 16():841-851. PubMed ID: 33824584
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence-based analysis of peripheral arterial disease screening based on the WHO criteria.
    Shah S; Antoniou GA; Torella F
    Int Angiol; 2017 Aug; 36(4):299-305. PubMed ID: 26344513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The burden of peripheral artery disease and the role of antiplatelet therapy.
    Aronow H; Hiatt WR
    Postgrad Med; 2009 Jul; 121(4):123-35. PubMed ID: 19641278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long term prognostic utility of coronary CT angiography in patients with no modifiable coronary artery disease risk factors: Results from the 5 year follow-up of the CONFIRM International Multicenter Registry.
    Cheruvu C; Precious B; Naoum C; Blanke P; Ahmadi A; Soon J; Arepalli C; Gransar H; Achenbach S; Berman DS; Budoff MJ; Callister TQ; Al-Mallah MH; Cademartiri F; Chinnaiyan K; Rubinshtein R; Marquez H; DeLago A; Villines TC; Hadamitzky M; Hausleiter J; Shaw LJ; Kaufmann PA; Cury RC; Feuchtner G; Kim YJ; Maffei E; Raff G; Pontone G; Andreini D; Chang HJ; Min JK; Leipsic J
    J Cardiovasc Comput Tomogr; 2016; 10(1):22-7. PubMed ID: 26719237
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebrovascular disease and intracranial artery stenosis in patients with symptomatic peripheral artery disease.
    Aizawa H; Azuma N; Katayama T; Hasebe N; Inaba M; Sasajima T; Uchiyama S
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):825-31. PubMed ID: 21703877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial.
    Muhlestein JB; Lappé DL; Lima JA; Rosen BD; May HT; Knight S; Bluemke DA; Towner SR; Le V; Bair TL; Vavere AL; Anderson JL
    JAMA; 2014 Dec; 312(21):2234-43. PubMed ID: 25402757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
    Angiolillo DJ; Bernardo E; Sabaté M; Jimenez-Quevedo P; Costa MA; Palazuelos J; Hernández-Antolin R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Guzman LA; Bass TA; Macaya C; Fernandez-Ortiz A
    J Am Coll Cardiol; 2007 Oct; 50(16):1541-7. PubMed ID: 17936152
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiplatelet therapy in peripheral artery disease.
    Violi F; Basili S; Berger JS; Hiatt WR
    Handb Exp Pharmacol; 2012; (210):547-63. PubMed ID: 22918746
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence, source, determinants, and prognostic impact of major bleeding in outpatients with stable coronary artery disease.
    Hamon M; Lemesle G; Tricot O; Meurice T; Deneve M; Dujardin X; Brufau JM; Bera J; Lamblin N; Bauters C
    J Am Coll Cardiol; 2014 Oct; 64(14):1430-6. PubMed ID: 25277612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.